Alembic Pharma: Received USFDA Final Approval for Fingolimod Capsules, 0.5 mg. Fingolimod Capsules, 0.5 mg, have an estimated ...
The Mid-Cap Growth Strategy underperformed the Russell Midcap Growth Index in Q1 2026 due to thematic weakness in software.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results